chartexchange

NeOnc CEO Buys More Shares Below $5 as NTHI Secures FDA Meeting to Discuss Phase 3 Trial

GlobeNewswire Inc. | Nov 12, 2026 10:13 AM EST

NeOnc’s (NASDAQ: NTHI) CEO purchased another 70,000 shares in the open market, bringing his recent purchases to 150,000 shares before FDA meetings

Read original article